Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis

Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis

Aim. To study effectiveness and safety of long-term monotherapy with АСГ inhibitor moexipril, as well as its combination with diuretic hydrochlorthiazide (HCT), in postmenopausal women with arterial hypertension (AH). Material and methods. In total, 38 women with postmenopause duration of 5 years an...

Full description

Bibliographic Details
Main Authors:	O. D. Ostroumova, E. A. Smolyarchuk, E. G. Shorikova, V. A. Polikarpov, M. P. Rubin, S. V. Paukov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	arterial hypertension women postmenopause osteoporosis densitometry ace inhibitors
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1567

Similar Items

Moexipril and arterial hypertension treatment in postmenopausal women
by: E. F. Litvinovich
Published: (2006-04-01)

Moexipril in postmenopausal women with arterial hypertension
by: M. G. Glezer, et al.
Published: (2005-02-01)

HYPERTENSION AND OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Marina Rašić Popović, et al.
Published: (2009-04-01)

Comparative Evaluation of Two Noninvasive Methods of Study of Bone Density in Women of Uzbek Population
by: D.Sh. Azizova, et al.
Published: (2013-04-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

Outpatient dual-energy x-ray osteodensitometry in diagnosis of early disorders of mineral bone density and monitoring of postmenopausal osteoporosis treatment
by: M P Rubin, et al.
Published: (2009-03-01)

The prevalence and structure of major risk factors in women with postmenopausal osteoporosis
by: I.V. Pankiv
Published: (2018-11-01)

Clinical and laboratory comparison in postmenopausal osteoporosis with normal and enhanced function of the parathyroid glands
by: K. A. Saveleva, et al.
Published: (2015-06-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

Osteoporosis in women in menopause/postmenopause: what to do?
by: E. V. Kulchavenya, et al.
Published: (2021-01-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women
by: Yi‐ran Yang, et al.
Published: (2019-12-01)

Osteoporosis: diagnosis, prevention and treatment in outpatient setting
by: Mark Pavlovich Rubin, et al.
Published: (2011-01-01)

Management of postmenopausal osteoporosis
by: Yeap SS, et al.
Published: (2013-10-01)

Prevalence of osteoporosis in postmenopausal women at Srinagarind Hospital, Khon Kaen University
by: Surangtip Surangtip, et al.
Published: (2010-03-01)

MOLECULAR GENETIC TESTING OF OSTEOPOROSIS SUSCEPTIBILITY IN POSTMENOPAUSAL WOMEN IN MOSCOW
by: V A Myakotkin, et al.
Published: (2011-04-01)

Low persistence with oral biphosphonate treatment in postmenopausal osteoporosis
by: Carla Torre, et al.
Published: (2019-04-01)

The effect of smoking on the response to raloxifene treatment in postmenopausal osteoporosis
by: Savaş Erdem, et al.
Published: (2012-12-01)

Evaluation of Serum Osteocalcin Level in Iraqi Postmenopausal Women with Primary Osteoporosis
by: Rana A. Hamdi
Published: (2013-07-01)

Application of Osteorisk to postmenopausal patients with osteoporosis
by: Marcelo Luis Steiner, et al.

Frequency of diagnosis of postmenopausal osteoporosis of the spine, distant radius and extravertebral fractures in women with normal body mass, overweight and obesity
by: A A Popov, et al.
Published: (2008-05-01)

Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009-05-01)

Vertebral Fracture in Postmenopausal Women with and without Osteoporosis
by: Merih Özgen, et al.
Published: (2017-08-01)

VITAMIN D STATUS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
by: Saša Milenković, et al.
Published: (2010-12-01)

NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION
by: O. D. Ostroumova, et al.
Published: (2016-01-01)

Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01)

Current approaches to the diagnosis and treatment of postmenopausal osteoporosis
by: Irina Aleksandrovna Baranova, et al.
Published: (2009-10-01)

Long-Term Treatment of Postmenopausal Osteoporosis
by: Jacques P. Brown
Published: (2021-06-01)

POSTMENOPAUSAL OSTEOPOROSIS – AN EXPLORATIVE LITERATURE REVIEW
by: Iulian Ștefan HOLUBIAC, et al.
Published: (2019-12-01)

RISK ASSESSMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Z. Shukerova
Published: (2020-12-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01)

The Effect of Continous or Intermittent Calcitonin in the Treatment of Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-03-01)

β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis
by: Funda Taşçıoğlu, et al.
Published: (2003-06-01)

The Relationship Between Postmenopausal Osteoporosis and Autophagic Gene Polymorphisms
by: Türkan Turgay, et al.
Published: (2020-08-01)

Osteoporosis treatment in postmenopausal women with pre-existing fracture
by: Ming-Huei Cheng, et al.
Published: (2012-06-01)

Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

THE INFLUENCE OF POSTMENOPAUSAL OSTEOPOROSIS AND SUBCLINICAL VERTEBRAL FRACTURES ON POSTMENOPAUSAL WOMEN’S QUALITY OF LIFE
by: L. A. Marchenkova, et al.
Published: (2016-02-01)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)